Herbal Supplements During Pregnancy: The Don't-Take List
Pregnancy is the period of human life with the highest stakes for a supplement-safety conversation, yet population data consistently show 20–60% of pregnant women use at least one herbal product. Many do so under the assumption that "natural" implies safe in pregnancy. The pharmacologic reality is that most herbal supplements have not been formally tested in pregnant women, several have well-documented teratogenic, abortifacient, or pre-term-labor-inducing effects, and U.S. supplement labeling does not require pregnancy warnings. This is the don't-take list and the why behind it.
Definite Avoid
Several herbs have either firm clinical evidence of harm in pregnancy or strong pharmacologic plausibility supported by case reports. Pennyroyal: hepatotoxic and abortifacient; deaths recorded. Black cohosh: stimulates uterine contractility; not for pregnancy except in some labor-induction protocols at term under midwifery supervision. Blue cohosh: cardiotoxic to fetus; multiple reports of newborn cardiac injury after late-pregnancy use. Pleurisy root: cardiac glycoside content. Comfrey: pyrrolizidine alkaloids cause hepatic veno-occlusive disease; not for any oral use, pregnant or not. Ephedra/Ma Huang: vasoconstrictive and stimulant; banned by FDA but still encountered in imported products. Yohimbe: cardiac and CNS effects; no pregnancy safety data. Saw palmetto: anti-androgenic; theoretical concern for male fetal development. Goldenseal: contains berberine, which displaces bilirubin from albumin and may cause neonatal jaundice or kernicterus.
Likely Avoid (Insufficient Safety Data, Plausible Risk)
St. John's Wort: serotonergic effects, drug interactions; limited human pregnancy data. Kava: hepatotoxic in adults; no pregnancy data; CDC has issued advisories. Ashwagandha: traditional use as an abortifacient in some Ayurvedic texts; modulates HPA axis; not safety-tested in pregnancy. Tribulus: animal data suggest teratogenicity. Dong quai: emmenagogue traditionally used to induce menstruation; abortifacient potential. Feverfew: traditionally used to expel placenta; emmenagogue properties. Senna at high doses: uterine stimulant; the AAP previously advised against repeat use in pregnancy though acceptable as occasional short-term laxative. Aloe vera oral: cathartic and uterine stimulant.
Limited but Generally Acceptable
A small number of herbs have either reasonable safety data or long-tradition pregnancy use without documented harm. Ginger: ACOG-endorsed for pregnancy nausea at ~1 g/day. Cranberry: limited pregnancy data; appears safe at standard urinary-tract supplement doses. Red raspberry leaf: traditionally used in late pregnancy; small RCTs show no harm but no clear benefit either. Peppermint tea: standard culinary doses appear safe. Chamomile tea: standard dietary doses appear safe; concentrated extracts are not well-studied. Garlic: standard culinary doses safe; high-dose supplements may have antiplatelet effects.
The Methodological Gap
Pregnant women are systematically excluded from the clinical trials that establish supplement safety. The FDA's pregnancy-labeling rule (PLLR) does not apply to dietary supplements. The result is that supplement labels often carry no pregnancy warning even for ingredients with strong contraindications. The American College of Obstetricians and Gynecologists, the National Center for Complementary and Integrative Health (NCCIH), and the LactMed database remain the most reliable resources; but for many herbs, the most accurate clinical statement is "we do not know."
Talk to Your Provider, Not Just the Cashier
Disclose all supplement use to your obstetric provider at every visit. Bring the actual bottles to the first prenatal appointment. The first trimester is the highest-risk window for organogenesis but no period of pregnancy is risk-free for unstudied compounds.
The Multi-Ingredient Trap
Many over-the-counter pregnancy and "fertility" supplements combine 10+ ingredients including herbs not on standard pregnancy-safety lists. Reading the full ingredient panel matters — "calming blend" or "sleep support" formulations frequently include ashwagandha, chamomile concentrate, valerian, kava, or skullcap, several of which fall in the avoid columns above.
Sources
- Dante G, Bellei G, Neri I, Facchinetti F. "Herbal therapies in pregnancy: what works?" Current Opinion in Obstetrics & Gynecology, 2014;26(2):83–91. PMID 24535329.
- Bjornsson HK, Bjornsson ES. "Drug-induced liver injury due to herbal and dietary supplements." Liver International, 2019;39(9):1773–1779. PMID 31379104.
- Ernst E. "Herbal medicinal products during pregnancy: are they safe?" BJOG, 2002;109(3):227–235. PMID 11950176.
- Marcus DM, Snodgrass WR. "Do no harm: avoidance of herbal medicines during pregnancy." Obstetrics & Gynecology, 2005;105(5 Pt 1):1119–1122. PMID 15863554.
- Anderson PO. "Herbal Use During Breastfeeding." Breastfeeding Medicine, 2017;12(9):507–509. PMID 28783359.
- Wright TL, Cui X. "Hepatic Veno-Occlusive Disease from Comfrey Tea." JAMA Internal Medicine, 1989;149(11):2438. PMID 2802903.
- Jones TK, Lawson BM. "Profound neonatal congestive heart failure caused by maternal consumption of blue cohosh herbal medication." Journal of Pediatrics, 1998;132(3 Pt 1):550–552. PMID 9544922.
- Centers for Disease Control and Prevention. "Hepatic toxicity possibly associated with kava-containing products — United States, Germany, and Switzerland, 1999–2002." MMWR, 2002;51(47):1065–1067. PMID 12466745.
- Anderson IB, Mullen WH, Meeker JE, et al. "Pennyroyal toxicity: measurement of toxic metabolite levels in two cases and review of the literature." Annals of Internal Medicine, 1996;124(8):726–734. PMID 8633832.
- National Institutes of Health, NCCIH. "Herbs at a Glance" series; LactMed database. Updated 2024.
Reviewed against 10 peer-reviewed/regulatory sources.